Cargando…

Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy

BACKGROUND: Immunoglobulin A nephropathy (IgAN) is the most common glomerulonephritis worldwide, characterized by mesangial polymeric IgA1 deposition. IgAN is believed to develop owing to aberrant mucosal immunoreaction against commensals in the tonsils. However, the exact interrelation between path...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Hiroki, Goto, Shin, Takahashi, Nao, Tsuchida, Masafumi, Watanabe, Hirofumi, Yamamoto, Suguru, Kaneko, Yoshikatsu, Higashi, Koichi, Mori, Hiroshi, Nakamura, Yukio, Horii, Arata, Kurokawa, Ken, Narita, Ichiei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771982/
https://www.ncbi.nlm.nih.gov/pubmed/33099625
http://dx.doi.org/10.1093/ndt/gfaa223
_version_ 1783629782688202752
author Yamaguchi, Hiroki
Goto, Shin
Takahashi, Nao
Tsuchida, Masafumi
Watanabe, Hirofumi
Yamamoto, Suguru
Kaneko, Yoshikatsu
Higashi, Koichi
Mori, Hiroshi
Nakamura, Yukio
Horii, Arata
Kurokawa, Ken
Narita, Ichiei
author_facet Yamaguchi, Hiroki
Goto, Shin
Takahashi, Nao
Tsuchida, Masafumi
Watanabe, Hirofumi
Yamamoto, Suguru
Kaneko, Yoshikatsu
Higashi, Koichi
Mori, Hiroshi
Nakamura, Yukio
Horii, Arata
Kurokawa, Ken
Narita, Ichiei
author_sort Yamaguchi, Hiroki
collection PubMed
description BACKGROUND: Immunoglobulin A nephropathy (IgAN) is the most common glomerulonephritis worldwide, characterized by mesangial polymeric IgA1 deposition. IgAN is believed to develop owing to aberrant mucosal immunoreaction against commensals in the tonsils. However, the exact interrelation between pathogenic IgA and mucosal microbiota in IgAN patients is unclear. METHODS: Biopsy-proven IgAN or recurrent tonsillitis (RT) patients who had undergone tonsillectomy were enrolled. We used 16S ribosomal RNA gene amplicon sequencing with a flow cytometry-based bacterial cell sorting technique) and immunoglobulin repertoire sequencing of the IgA heavy chain to characterize IgA-coated bacteria of the tonsillar microbiota (IgA-SEQ) and their corresponding IgA repertoire. Furthermore, we fractionated patient serum using gel-filtration chromatography and performed flow cytometry-based analysis of IgA binding to bacteria cultured from incised tonsils. RESULTS: Tonsillar proliferation-inducing ligand and B-cell activating factor levels were significantly higher in IgAN than in RT patients. IgA-SEQ for tonsillar microbiota revealed the preferential binding ability of IgA to Bacteroidetes in IgAN tonsils compared with those from RT patients. Expression of immunoglobulin heavy (IGH) constant alpha 1 with IGH variable 3–30 was significantly higher in IgAN than that in RT, and positively correlated with the IgA-coated enrichment score of Bacteroidetes. Serum polymeric IgA, comprising high levels of GdIgA1, exhibited considerable binding to Bacteroidetes strains cultured from the tonsils of IgAN patients. CONCLUSIONS: These findings provide evidence that aberrant mucosal immune responses to tonsillar anaerobic microbiota, primarily consisting of members of the phylum Bacteroidetes, are involved in IgAN pathophysiology.
format Online
Article
Text
id pubmed-7771982
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77719822021-01-05 Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy Yamaguchi, Hiroki Goto, Shin Takahashi, Nao Tsuchida, Masafumi Watanabe, Hirofumi Yamamoto, Suguru Kaneko, Yoshikatsu Higashi, Koichi Mori, Hiroshi Nakamura, Yukio Horii, Arata Kurokawa, Ken Narita, Ichiei Nephrol Dial Transplant ORIGINAL ARTICLES BACKGROUND: Immunoglobulin A nephropathy (IgAN) is the most common glomerulonephritis worldwide, characterized by mesangial polymeric IgA1 deposition. IgAN is believed to develop owing to aberrant mucosal immunoreaction against commensals in the tonsils. However, the exact interrelation between pathogenic IgA and mucosal microbiota in IgAN patients is unclear. METHODS: Biopsy-proven IgAN or recurrent tonsillitis (RT) patients who had undergone tonsillectomy were enrolled. We used 16S ribosomal RNA gene amplicon sequencing with a flow cytometry-based bacterial cell sorting technique) and immunoglobulin repertoire sequencing of the IgA heavy chain to characterize IgA-coated bacteria of the tonsillar microbiota (IgA-SEQ) and their corresponding IgA repertoire. Furthermore, we fractionated patient serum using gel-filtration chromatography and performed flow cytometry-based analysis of IgA binding to bacteria cultured from incised tonsils. RESULTS: Tonsillar proliferation-inducing ligand and B-cell activating factor levels were significantly higher in IgAN than in RT patients. IgA-SEQ for tonsillar microbiota revealed the preferential binding ability of IgA to Bacteroidetes in IgAN tonsils compared with those from RT patients. Expression of immunoglobulin heavy (IGH) constant alpha 1 with IGH variable 3–30 was significantly higher in IgAN than that in RT, and positively correlated with the IgA-coated enrichment score of Bacteroidetes. Serum polymeric IgA, comprising high levels of GdIgA1, exhibited considerable binding to Bacteroidetes strains cultured from the tonsils of IgAN patients. CONCLUSIONS: These findings provide evidence that aberrant mucosal immune responses to tonsillar anaerobic microbiota, primarily consisting of members of the phylum Bacteroidetes, are involved in IgAN pathophysiology. Oxford University Press 2020-10-25 /pmc/articles/PMC7771982/ /pubmed/33099625 http://dx.doi.org/10.1093/ndt/gfaa223 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle ORIGINAL ARTICLES
Yamaguchi, Hiroki
Goto, Shin
Takahashi, Nao
Tsuchida, Masafumi
Watanabe, Hirofumi
Yamamoto, Suguru
Kaneko, Yoshikatsu
Higashi, Koichi
Mori, Hiroshi
Nakamura, Yukio
Horii, Arata
Kurokawa, Ken
Narita, Ichiei
Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy
title Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy
title_full Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy
title_fullStr Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy
title_full_unstemmed Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy
title_short Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy
title_sort aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin a nephropathy
topic ORIGINAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771982/
https://www.ncbi.nlm.nih.gov/pubmed/33099625
http://dx.doi.org/10.1093/ndt/gfaa223
work_keys_str_mv AT yamaguchihiroki aberrantmucosalimmunoreactiontotonsillarmicrobiotainimmunoglobulinanephropathy
AT gotoshin aberrantmucosalimmunoreactiontotonsillarmicrobiotainimmunoglobulinanephropathy
AT takahashinao aberrantmucosalimmunoreactiontotonsillarmicrobiotainimmunoglobulinanephropathy
AT tsuchidamasafumi aberrantmucosalimmunoreactiontotonsillarmicrobiotainimmunoglobulinanephropathy
AT watanabehirofumi aberrantmucosalimmunoreactiontotonsillarmicrobiotainimmunoglobulinanephropathy
AT yamamotosuguru aberrantmucosalimmunoreactiontotonsillarmicrobiotainimmunoglobulinanephropathy
AT kanekoyoshikatsu aberrantmucosalimmunoreactiontotonsillarmicrobiotainimmunoglobulinanephropathy
AT higashikoichi aberrantmucosalimmunoreactiontotonsillarmicrobiotainimmunoglobulinanephropathy
AT morihiroshi aberrantmucosalimmunoreactiontotonsillarmicrobiotainimmunoglobulinanephropathy
AT nakamurayukio aberrantmucosalimmunoreactiontotonsillarmicrobiotainimmunoglobulinanephropathy
AT horiiarata aberrantmucosalimmunoreactiontotonsillarmicrobiotainimmunoglobulinanephropathy
AT kurokawaken aberrantmucosalimmunoreactiontotonsillarmicrobiotainimmunoglobulinanephropathy
AT naritaichiei aberrantmucosalimmunoreactiontotonsillarmicrobiotainimmunoglobulinanephropathy